K. C. Herold, S. E. Gitelman, U. Masharani, W. Hagopian, B. Bisikirska et al., A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes, Diabetes, vol.54, pp.1763-1769, 2005.

X. Luo, K. C. Herold, and S. D. Miller, Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity, vol.32, pp.488-499, 2010.

S. Manicassamy and B. Pulendran, Dendritic cell control of tolerogenic responses, Immunol. Rev, vol.241, pp.206-227

C. C. Denucci, J. S. Mitchell, and Y. Shimizu, Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there, Crit. Rev. Immunol, vol.29, pp.87-109, 2009.

E. O. Owens, Endogenous carbon monoxide production in disease, Clin. Biochem, vol.43, pp.1183-1188, 2010.

A. A. Chora, P. Fontoura, A. Cunha, T. F. Pais, S. Cardoso et al., Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation, J. Clin. Invest, vol.117, pp.438-447, 2007.

M. Li, S. Peterson, D. Husney, M. Inaba, K. Guo et al., Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice, Cell Cycle, vol.6, pp.567-571, 2007.

C. M. Hu, H. H. Lin, M. T. Chiang, P. F. Chang, and L. Y. Chau, Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice, Diabetes, vol.56, pp.1240-1247, 2007.

Z. W. Xia, W. W. Zhong, L. Q. Xu, J. L. Sun, Q. X. Shen et al., Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation, J. Immunol, vol.177, pp.5936-5945, 2006.

C. Chauveau, D. Bouchet, J. Roussel, P. Mathieu, C. Braudeau et al., Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection, Am. J. Transplant, vol.2, pp.581-592, 2002.

C. Braudeau, D. Bouchet, L. Tesson, S. Iyer, S. Remy et al., Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer, Gene Ther, vol.11, pp.701-710, 2004.

M. P. Soares, Y. Lin, J. Anrather, E. Csizmadia, K. Takigami et al., Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nat. Med, vol.4, pp.1073-1077, 1998.

F. Bach, W. Hancock, and C. Ferran, Protective genes expressed in endothelial cells: a regulatory response to injury, Immunol. Today, vol.18, pp.483-486, 1997.

W. W. Hancock, R. Buelow, M. H. Sayegh, and L. A. Turka, Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes, Nat. Med, vol.4, pp.1392-1396, 1998.

P. Blancou and I. Anegon, Editorial: heme oxygenase-1 and dendritic cells: what else?, J. Leukoc. Biol, vol.87, pp.185-187, 2010.

C. Chauveau, S. Remy, P. Royer, M. Hill, S. Tanguy-royer et al., Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression, Blood, vol.106, pp.1694-1702, 2005.

S. Remy, P. Blancou, L. Tesson, V. Tardif, R. Brion et al., Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity, J. Immunol, vol.182, pp.1877-1884, 2009.

D. L. Dong, C. Chen, W. Huang, Y. Chen, X. L. Zhang et al., Tricarbonyldichlororuthenium (II) dimer (CORM2) activates non-selective cation current in human endothelial cells independently of carbon monoxide releasing, Eur. J. Pharmacol, vol.590, pp.99-104, 2008.

D. Lo, J. Freedman, S. Hesse, R. D. Palmiter, R. L. Brinster et al., Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells, Eur. J. Immunol, vol.22, pp.1013-1022, 1992.

N. Bercovici, A. Heurtier, C. Vizler, N. Pardigon, C. Cambouris et al., Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage, J. Immunol, vol.165, pp.202-210, 2000.
URL : https://hal.archives-ouvertes.fr/pasteur-01659368

A. Hanninen, R. Nurmela, M. Maksimow, J. Heino, S. Jalkanen et al., Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets, Am. J. Pathol, vol.170, pp.240-250, 2007.

M. A. Doucey, D. F. Legler, M. Faroudi, N. Boucheron, P. Baumgaertner et al., The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation, J. Biol. Chem, vol.278, pp.26983-26991, 2003.

J. Listopad, K. Asadullah, C. Sievers, T. Ritter, C. Meisel et al., Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells, Exp. Dermatol, vol.16, pp.661-670, 2007.

M. F. Mashreghi, R. Klemz, I. S. Knosalla, B. Gerstmayer, U. Janssen et al., Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3, J. Immunol, vol.180, pp.7919-7930, 2008.

C. Nembrini, B. Abel, M. Kopf, and B. J. Marsland, Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells, J. Immunol, vol.176, pp.7180-7188, 2006.

J. M. Curtsinger, D. C. Lins, and M. F. Mescher, Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function, J. Exp. Med, vol.197, pp.1141-1151, 2003.

H. M. Clarke, S. Shrivastava, R. Motterlini, P. Sawle, D. Chen et al., Donor HO-1 expression inhibits intimal hyperplasia in unmanipulated graft recipients: a potential role for CD8+ T-cell modulation by carbon monoxide, Transplantation, vol.88, pp.653-661, 2009.

A. Y. Savinov, F. S. Wong, A. C. Stonebraker, and A. V. Chervonsky, Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells, J. Exp. Med, vol.197, pp.643-656, 2003.

A. Y. Savinov, D. V. Rozanov, V. S. Golubkov, F. S. Wong, and A. Y. Strongin, Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas, J. Biol. Chem, vol.280, pp.27755-27758, 2005.

G. Fousteri, A. Dave, T. Juntti, and M. Von-herrath, CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virallyinduced autoimmune diabetes, J. Autoimmun, vol.32, pp.70-77, 2009.

R. Forster, A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-muller et al., CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs, Cell, vol.99, pp.23-33, 1999.

C. Carvalho-pinto, M. I. Garcia, L. Gomez, A. Ballesteros, A. Zaballos et al., Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice, Eur. J. Immunol, vol.34, pp.548-557, 2004.

S. Frigerio, T. Junt, B. Lu, C. Gerard, U. Zumsteg et al., Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis, Nat. Med, vol.8, pp.1414-1420, 2002.

S. Ghosh, E. Goldin, F. H. Gordon, H. A. Malchow, J. Rask-madsen et al.,

, N. Engl. J. Med, vol.348, pp.24-32, 2003.

D. H. Miller, O. A. Khan, W. A. Sheremata, L. D. Blumhardt, G. P. Rice et al., A controlled trial of Natalizumab for relapsing multiple sclerosis, N. Engl. J. Med, vol.348, pp.15-23, 2003.

M. P. Soares, M. P. Seldon, I. P. Gregoire, T. Vassilevskaia, P. O. Berberat et al., Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation

, J. Immunol, vol.172, pp.3553-3563, 2004.

M. P. Seldon, G. Silva, N. Pejanovic, R. Larsen, I. P. Gregoire et al., Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276, J. Immunol, vol.179, pp.7840-7851, 2007.

C. Bergstraesser, S. Hoeger, H. Song, L. Ermantraut, M. Hottenrot et al., Inhibition of VCAM-1 expression in endothelial cells by CORM-3: the role of the ubiquitin-proteasome system, p38, and mitochondrial respiration. Free Radic, Biol. Med. 2012, vol.52, pp.794-802

M. Kirino, Y. Kirino, M. Takeno, Y. Nagashima, K. Takahashi et al., Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease, J. Allergy Clin. Immunol, vol.122, pp.291-298, 2008.

A. E. Morelli and A. W. Thomson, Tolerogenic dendritic cells and the quest for transplant tolerance, Nat. Rev. Immunol, vol.7, pp.610-621, 2007.

R. M. Steinman, D. Hawiger, and M. C. Nussenzweig, Tolerogenic dendritic cells, Annu. Rev. Immunol, vol.21, pp.685-711, 2003.

R. J. Creusot, S. S. Yaghoubi, P. Chang, J. Chia, C. H. Contag et al., Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells, Blood, vol.113, pp.6638-6647, 2009.

F. Mori, L. Bianchi, N. Pucci, C. Azzari, M. De-martino et al., CD4+CD25+Foxp3+ T regulatory cells are not involved in oral desensitization, Int. J. Immunopathol. Pharmacol, vol.23, pp.359-361, 2010.

D. Falb, T. J. Briner, G. H. Sunshine, C. R. Bourque, M. Luqman et al., Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy, Eur. J. Immunol, vol.26, pp.130-135, 1996.

E. R. Kearney, K. A. Pape, D. Y. Loh, and M. K. Jenkins, Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo, Immunity, vol.1, pp.327-339, 1994.

S. Brocke, K. Gijbels, M. Allegretta, I. Ferber, C. Piercy et al., Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein, Nature, vol.379, pp.343-346, 1996.

I. Raz, D. Elias, A. Avron, M. Tamir, M. Metzger et al., Betacell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial, Lancet, vol.358, pp.1749-1753, 2001.

J. S. Petersen, S. Bregenholt, V. Apostolopolous, D. Homann, T. Wolfe et al., Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes, Clin. Exp. Immunol, vol.134, pp.38-45, 2003.

A. Goubier, B. Dubois, H. Gheit, G. Joubert, F. Villard-truc et al., Plasmacytoid dendritic cells mediate oral tolerance, Immunity, vol.29, pp.464-475, 2008.

C. Burkhart, G. Y. Liu, S. M. Anderton, B. Metzler, and D. C. Wraith, Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10, Int. Immunol, vol.11, pp.1625-1634, 1999.

I. Apostolou, V. Boehmer, and H. , The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations. J. Autoimmun, vol.22, pp.111-114, 2004.

E. Piaggio, L. T. Mars, C. Cassan, J. Cabarrocas, M. Hofstatter et al., Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance, Proc. Natl

. Acad, . Sci, and . Usa, , vol.104, pp.9393-9398, 2007.

S. Bedoui, P. G. Whitney, J. Waithman, L. Eidsmo, L. Wakim et al., Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells, Nat. Immunol, vol.10, pp.488-495, 2009.

D. J. Morgan, R. Liblau, B. Scott, S. Fleck, H. O. Mcdevitt et al., CD8(+) T cell-mediated spontaneous diabetes in neonatal mice, J. Immunol, vol.157, pp.978-983, 1996.

, Abbreviations: CO: carbon monoxide · CORM: CO-releasing molecule · gCO: gazeous carbon monoxide · HO: heme oxygenase Full correspondence: Dr. Philippe Blancou, CHU Hotel Dieu, UMR INSERM 1064, vol.30, pp.33-240

, philippe.blancou@gmail.com Current address: Dr. Thomas Simon, INSERM, UMR 1064